Particularly, CSF IL-6 levels correlated with anti-AQP-4 levels and disease severity in NMO patients, and anti-AQP-4 positive NMO patients had higher serum/CSF IL-6 levels than anti-Aqp-4 negative patients [85]. Here, IL6 is linked to neuromyelitis optica.